世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000031330

ドラッグデリバリー装置市場-2030年までの世界需要分析および事業機会の見通し

Fatpos Global

Drug Delivery Devices Market Segmentation by Device Type (Smart Pills, Inhalers, Drug Eluting Stents, Safety Syringes, Implantable Drug Delivery Device, Transdermal Patches, and Others); by Route of Administration (Oral, Transdermal, Injectable, and Others); and by Distribution Channel (Hospital, Pharmacies, Surgical Centers, and Others) - Global Demand Analysis & Opportunity Outlook 2030

発刊日 2022/01

言語英語

体裁Word-PDF/155ページ

ライセンス/価格155ページ

0000031330

Single
Enterprise
Corporate

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。Word-PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

ドラッグデリバリー装置市場:装置の種類別分類(スマートピル、吸入器、薬剤溶出ステント、安全注射器、埋め込み型ドラッグデリバリー装置、経皮パッチなど)、投与経路別(経口、経皮、注射、その他)、流通経路別(病院、薬局、外科センター、その他)-世界の需要分析と事業機会の見通し2030

市場概要

Fatpos Globalは、ドラッグデリバリー装置市場-2014年から2020年までの市場規模、シェア、動向の分析、および2031年までの予測というタイトルのレポートを発刊しました。Fatpos Globalの調査によると、予測期間(2022〜2030年)のCAGRは5.5%と推定され、2030年までに市場規模は176億1,100万ドルに達すると予測されます。グローバル市場の包括的な見通しを示すために、市場規模、シェア、売上高、予測動向、供給、生産、需要、業界、CAGRなどのいくつかの決定的な要因を深く理解することに重点を置いています。

レポート詳細

目次

Contents

1. Executive Summary

2. Drug Delivery Devices Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms

3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation

4. Average Pricing Analysis

5. Macro-Economic Indicators

6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends

7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix

8. Recent Development, Policies & Regulatory Landscape

9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis

10. Drug Delivery Devices Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological

11. Drug Delivery Devices Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

12. Drug Delivery Devices Market : Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By network type: Market Share (2020-2030F)
12.2.1. Hardware , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Software , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Services , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By End user: Market Share (2020-2030F)
12.3.1. Manufacturing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Healthcare, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Energy and Utilities, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. IT & Telecom, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.5. Automotive and Transportation, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.6. Supply Chain and Logistics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.7. Government and Public Safety, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.8. Agriculture, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.9. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

Company Profile
Antares Pharma, Inc.
Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Novartis International AG
Johnson & Johnson
GlaxoSmithKline plc
Merck & Co., Inc.
Otsuka Pharmaceutical Co., Ltd.,
Abbott Laboratories
Cipla Limited
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

この商品のレポートナンバー

0000031330

TOP